J S Tobias

3.0k total citations · 1 hit paper
16 papers, 2.3k citations indexed

About

J S Tobias is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J S Tobias has authored 16 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J S Tobias's work include Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Research Studies (6 papers) and Breast Cancer Treatment Studies (3 papers). J S Tobias is often cited by papers focused on Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Research Studies (6 papers) and Breast Cancer Treatment Studies (3 papers). J S Tobias collaborates with scholars based in United Kingdom, United States and France. J S Tobias's co-authors include J. Houghton, Anthony Howell, Mitch Dowsett, Jack Cuzick, John Forbes, M Baum, A. Buzdar, Gershon Y. Locker, G Hoctin-Boes and R L Souhami and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

J S Tobias

15 papers receiving 2.2k citations

Hit Papers

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Com... 2005 2026 2012 2019 2005 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
    2005 1.7k citations Anthony Howell, Jack Cuzick et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J S Tobias United Kingdom 11 1.3k 1.1k 715 402 291 16 2.3k
G Hoctin-Boes Netherlands 8 1.4k 1.0× 1.5k 1.3× 958 1.3× 392 1.0× 278 1.0× 12 2.4k
Holly Anderson United States 8 1.5k 1.1× 797 0.7× 760 1.1× 573 1.4× 356 1.2× 10 2.5k
Monica Castiglione Switzerland 17 1.4k 1.1× 1.3k 1.1× 1.3k 1.9× 522 1.3× 258 0.9× 26 2.4k
Simon Cawthorn United Kingdom 23 1.7k 1.3× 1.5k 1.3× 1.3k 1.8× 495 1.2× 305 1.0× 54 3.6k
Alexander Liede United States 29 916 0.7× 1.3k 1.2× 415 0.6× 459 1.1× 589 2.0× 81 2.8k
M Baum United Kingdom 11 2.0k 1.5× 2.4k 2.1× 1.6k 2.2× 573 1.4× 455 1.6× 34 3.6k
H.T. Ford United Kingdom 33 1.8k 1.4× 575 0.5× 1.2k 1.7× 807 2.0× 459 1.6× 77 3.5k
Reena S. Cecchini United States 20 1.8k 1.3× 1.1k 1.0× 959 1.3× 422 1.0× 393 1.4× 49 2.9k
Jeffrey S. Abrams United States 33 2.2k 1.7× 1.3k 1.1× 1.7k 2.3× 811 2.0× 494 1.7× 104 4.4k
A. Buzdar United States 7 1.2k 0.9× 1.2k 1.1× 846 1.2× 356 0.9× 253 0.9× 16 2.0k

Countries citing papers authored by J S Tobias

Since Specialization
Citations

This map shows the geographic impact of J S Tobias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J S Tobias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J S Tobias more than expected).

Fields of papers citing papers by J S Tobias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J S Tobias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J S Tobias. The network helps show where J S Tobias may publish in the future.

Co-authorship network of co-authors of J S Tobias

This figure shows the co-authorship network connecting the top 25 collaborators of J S Tobias. A scholar is included among the top collaborators of J S Tobias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J S Tobias. J S Tobias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Souhami, R L, Helena Earl, C. M. Ash, et al.. (2015). Prognostic Factors in Patients with Small-Cell Lung Cancer: Preliminary Results from a Large Randomised Study. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 41. 77–82.
2.
Tobias, J S, Jayant S. Vaidya, Norman Williams, et al.. (2008). Breast cancer patients treated with intra-operative radiotherapy [IORT] alone when conventional external beam radiation therapy [EBRT] was not possible. Journal of Clinical Oncology. 26(15_suppl). 11517–11517. 2 indexed citations
3.
Vaidya, Jayant S., M Baum, J S Tobias, et al.. (2008). Efficacy of targeted intraoperative radiotherapy (Targit) boost after breast-conserving surgery: Updated results. Journal of Clinical Oncology. 26(15_suppl). 565–565. 3 indexed citations
4.
Bourhis, Jean, Aurélie Le Maître, Jean‐Pierre Pignon, et al.. (2006). Impact of age on treatment effect in locally advanced head and neck cancer (HNC): Two individual patient data meta-analyses. Journal of Clinical Oncology. 24(18_suppl). 5501–5501. 23 indexed citations
5.
Howell, Anthony, Jack Cuzick, M Baum, et al.. (2005). Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. The Lancet. 365(9453). 60–62. 1715 indexed citations breakdown →
6.
Slevin, ML, Patrick B. Wilson, TA Lister, et al.. (1996). Emotional support for cancer patients: what do patients really want?. British Journal of Cancer. 74(8). 1275–1279. 127 indexed citations
7.
Tobias, J S. (1994). Current Issues in Cancer: Cancer of the head and neck. BMJ. 308(6934). 961–966. 46 indexed citations
8.
Earl, Helena, R.M. Rudd, SG Spiro, et al.. (1991). A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. British Journal of Cancer. 64(3). 566–572. 39 indexed citations
9.
Miles, David, Helena Earl, R L Souhami, et al.. (1991). Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer.. Journal of Clinical Oncology. 9(2). 280–285. 47 indexed citations
10.
Earl, Helena, R L Souhami, C. M. Ash, et al.. (1989). Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. British Journal of Cancer. 59(5). 801–804. 39 indexed citations
11.
Blackledge, G., J. Mould, John Monaghan, et al.. (1989). The role of ifosfamide in cervical cancer.. PubMed. 16(1 Suppl 3). 60–7. 10 indexed citations
12.
Souhami, R L, Ian Bradbury, D M Geddes, et al.. (1986). Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Lung Cancer. 2(3). 220–220. 139 indexed citations
13.
Thomas, D. G. T., John L. Darling, E. Paul, et al.. (1985). Assay of anti-cancer drugs in tissue culture: Relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma. British Journal of Cancer. 51(4). 525–532. 29 indexed citations
14.
Souhami, R L, J S Tobias, I Bradbury, et al.. (1984). Radiotherapy in small cell cancer of the lung. BMJ. 289(6438). 190.1–190. 1 indexed citations
15.
Geddes, D M, Stephen Spiro, J S Tobias, R L Souhami, & P. Harper. (1984). Lung Cancer: Future Prospects. Recent results in cancer research. 92. 118–127. 2 indexed citations
16.
Spiro, SG, Sanjay Shah, P. Harper, et al.. (1983). Treatment of obstruction of the superior vena cava by combination chemotherapy with and without irradiation in small-cell carcinoma of the bronchus.. Thorax. 38(7). 501–505. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Hoctin-Boes Breakdown of academic impact, for papers by Holly Anderson Breakdown of academic impact, for papers by Monica Castiglione Breakdown of academic impact, for papers by Simon Cawthorn Breakdown of academic impact, for papers by Alexander Liede Breakdown of academic impact, for papers by M Baum Breakdown of academic impact, for papers by H.T. Ford Breakdown of academic impact, for papers by Reena S. Cecchini Breakdown of academic impact, for papers by Jeffrey S. Abrams Breakdown of academic impact, for papers by A. Buzdar
Rankless by CCL
2026